These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 19121356

  • 1. Effects of beta-amyloid on behavioral and amino acids spectrum in rats' brain and their modulation by embryonic proteins.
    Yenkoyan K, Safaryan K, Navasardyan G, Mkrtchyan L, Aghajanov M.
    Neurochem Int; 2009; 54(5-6):292-8. PubMed ID: 19121356
    [Abstract] [Full Text] [Related]

  • 2. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
    Townsend M, Cleary JP, Mehta T, Hofmeister J, Lesne S, O'Hare E, Walsh DM, Selkoe DJ.
    Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
    [Abstract] [Full Text] [Related]

  • 3. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
    Chavant F, Deguil J, Pain S, Ingrand I, Milin S, Fauconneau B, Pérault-Pochat MC, Lafay-Chebassier C.
    J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
    [Abstract] [Full Text] [Related]

  • 4. Soluble beta-amyloid[25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning.
    Holscher C, Gengler S, Gault VA, Harriott P, Mallot HA.
    Eur J Pharmacol; 2007 Apr 30; 561(1-3):85-90. PubMed ID: 17320856
    [Abstract] [Full Text] [Related]

  • 5. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z.
    Neuroscience; 2007 Jun 15; 147(1):28-36. PubMed ID: 17499931
    [Abstract] [Full Text] [Related]

  • 6. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
    Nakamura S, Murayama N, Noshita T, Katsuragi R, Ohno T.
    Eur J Pharmacol; 2006 Oct 24; 548(1-3):115-22. PubMed ID: 16952349
    [Abstract] [Full Text] [Related]

  • 7. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W, Guo F, Cheng L, Zhang JF, Qi JS.
    Neurosci Lett; 2009 Feb 06; 450(3):306-10. PubMed ID: 19059464
    [Abstract] [Full Text] [Related]

  • 8. Arginine vasopressin prevents against Abeta(25-35)-induced impairment of spatial learning and memory in rats.
    Pan YF, Chen XR, Wu MN, Ma CG, Qi JS.
    Horm Behav; 2010 Apr 06; 57(4-5):448-54. PubMed ID: 20138885
    [Abstract] [Full Text] [Related]

  • 9. Protective effect of Polygonum multiflorum Thunb on amyloid beta-peptide 25-35 induced cognitive deficits in mice.
    Um MY, Choi WH, Aan JY, Kim SR, Ha TY.
    J Ethnopharmacol; 2006 Mar 08; 104(1-2):144-8. PubMed ID: 16219438
    [Abstract] [Full Text] [Related]

  • 10. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades.
    Matos M, Augusto E, Oliveira CR, Agostinho P.
    Neuroscience; 2008 Oct 28; 156(4):898-910. PubMed ID: 18790019
    [Abstract] [Full Text] [Related]

  • 11. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
    Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, Matsuno T, Kawashima S, Nabeshima T.
    J Pharmacol Exp Ther; 2006 Jun 28; 317(3):1079-87. PubMed ID: 16474004
    [Abstract] [Full Text] [Related]

  • 12. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice.
    Tajima H, Kawasumi M, Chiba T, Yamada M, Yamashita K, Nawa M, Kita Y, Kouyama K, Aiso S, Matsuoka M, Niikura T, Nishimoto I.
    J Neurosci Res; 2005 Mar 01; 79(5):714-23. PubMed ID: 15678515
    [Abstract] [Full Text] [Related]

  • 13. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS, Rauw G, Baker GB, Kar S.
    Eur J Neurosci; 2008 Nov 01; 28(10):1989-2002. PubMed ID: 19046381
    [Abstract] [Full Text] [Related]

  • 14. Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat.
    Cheng G, Whitehead SN, Hachinski V, Cechetto DF.
    Neurobiol Dis; 2006 Jul 01; 23(1):140-51. PubMed ID: 16624564
    [Abstract] [Full Text] [Related]

  • 15. Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits.
    Chacón MA, Barría MI, Soto C, Inestrosa NC.
    Mol Psychiatry; 2004 Oct 01; 9(10):953-61. PubMed ID: 15098004
    [Abstract] [Full Text] [Related]

  • 16. Differential changes of neuroactive amino acids in samples obtained from discrete rat brain regions after systemic administration of saxitoxin.
    Cianca RC, Barbosa RD, Faro LR, Adan LV, Gago-Martínez A, Pallares MA.
    Neurochem Int; 2009 Oct 01; 54(5-6):308-13. PubMed ID: 19159655
    [Abstract] [Full Text] [Related]

  • 17. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation.
    Lee CL, Kuo TF, Wang JJ, Pan TM.
    J Neurosci Res; 2007 Nov 01; 85(14):3171-82. PubMed ID: 17663476
    [Abstract] [Full Text] [Related]

  • 18. The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.
    Ostrovskaya RU, Gruden MA, Bobkova NA, Sewell RD, Gudasheva TA, Samokhin AN, Seredinin SB, Noppe W, Sherstnev VV, Morozova-Roche LA.
    J Psychopharmacol; 2007 Aug 01; 21(6):611-9. PubMed ID: 17092975
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
    Kumar P, Kumar A.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):91-101. PubMed ID: 19445928
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Abeta25-35 model of Alzheimer's disease.
    Galoyan AA, Sarkissian JS, Chavushyan VA, Meliksetyan IB, Avagyan ZE, Poghosyan MV, Vahradyan HG, Mkrtchian HH, Abrahamyan DO.
    Alzheimers Dement; 2008 Sep 01; 4(5):332-44. PubMed ID: 18790460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.